Cantor E H, Kenessey A, Semenuk G, Spector S
Proc Natl Acad Sci U S A. 1984 Mar;81(5):1549-52. doi: 10.1073/pnas.81.5.1549.
The ability of calcium channel blockers to displace the binding of benzodiazepine ligands was investigated in rat heart, kidney, and brain. The dihydropyridine calcium channel blockers nifedipine and nitrendipine displaced the binding of the non-neuronal-site ligand [3H]Ro5-4864, but not that of the neuronal-site ligands [3H]flurazepam or [3H]clonazepam. The inhibition was competitive, with Ki values in the micromolar range. Other calcium channel blockers--i.e., verapamil and diltiazem--were inactive at both sites. Thus, non-neuronal benzodiazepines bind to a class of sites that also binds dihydropyridines. This implies a role for benzodiazepines in the mediation of calcium-dependent phenomena.
研究了钙通道阻滞剂在大鼠心脏、肾脏和大脑中取代苯二氮䓬配体结合的能力。二氢吡啶类钙通道阻滞剂硝苯地平和尼群地平能取代非神经元位点配体[3H]Ro5 - 4864的结合,但不能取代神经元位点配体[3H]氟西泮或[3H]氯硝西泮的结合。这种抑制是竞争性的,Ki值在微摩尔范围内。其他钙通道阻滞剂,即维拉帕米和地尔硫䓬,在这两个位点均无活性。因此,非神经元苯二氮䓬类药物与一类也能结合二氢吡啶的位点结合。这意味着苯二氮䓬类药物在钙依赖性现象的介导中发挥作用。